Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Kyverna Therapeutics Q1 EPS $(1.03) Misses $(0.99) Estimate

Author: Benzinga Newsdesk | May 13, 2025 03:14pm
Kyverna Therapeutics (NASDAQ:KYTX) reported quarterly losses of $(1.03) per share which missed the analyst consensus estimate of $(0.99) by 4.04 percent. This is a 8.04 percent increase over losses of $(1.12) per share from the same period last year.

Posted In: KYTX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist